Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

METABOLIC CRANIOPATHY

METABOLIC CRANIOPATHY Metabolic craniopathy has been defined as "a syndrome characterized clinically by variable and protean manifestations of a metabolic, endocrine and neuropsychiatric nature and roentgenologically by characteristic thickening of the internal tables of the skull."1 The condition has been commonly referred to as hyperostosis frontalis interna, but this is a less suitable designation since the changes observed in the skull do not appear to contribute to the clinical picture nor are they probably an essential part of the syndrome. The changes in the skull are moreover not always limited to the frontal bones, and hence the designation metabolic craniopathy would appear preferable. Other designations which have been used for certain forms of this disorder are the eponyms Morgagni's and Stewart-Morel's syndrome and the terms "cranial hyperostosis of the insane" and "calvarial hyperostosis." These too fit the condition less satisfactorily, however, than does the designation metabolic craniopathy. Although metabolic craniopathy is http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

METABOLIC CRANIOPATHY

GROLLMAN, ARTHUR; ROUSSEAU, J. P.
JAMA , Volume 126 (4) – Sep 23, 1944
Download PDF
5 pages

Loading next page...
 
/lp/american-medical-association/metabolic-craniopathy-EFyAGa0yuJ

References (5)

Publisher
American Medical Association
Copyright
Copyright © 1944 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1944.02850390011004
Publisher site
See Article on Publisher Site

Abstract

Metabolic craniopathy has been defined as "a syndrome characterized clinically by variable and protean manifestations of a metabolic, endocrine and neuropsychiatric nature and roentgenologically by characteristic thickening of the internal tables of the skull."1 The condition has been commonly referred to as hyperostosis frontalis interna, but this is a less suitable designation since the changes observed in the skull do not appear to contribute to the clinical picture nor are they probably an essential part of the syndrome. The changes in the skull are moreover not always limited to the frontal bones, and hence the designation metabolic craniopathy would appear preferable. Other designations which have been used for certain forms of this disorder are the eponyms Morgagni's and Stewart-Morel's syndrome and the terms "cranial hyperostosis of the insane" and "calvarial hyperostosis." These too fit the condition less satisfactorily, however, than does the designation metabolic craniopathy. Although metabolic craniopathy is

Journal

JAMA – American Medical Association

Published: Sep 23, 1944

There are no references for this article.